College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
 
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
 
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > Online Media Kit Index

  HPV Vaccine—Pap Testing
  and HPV Testing

 

Updated February 5, 2008

On June 8, 2006, the Federal Drug Administration approved a new vaccine to protect women from HPV, the leading cause of cervical cancer. While the announcement is good news for the public, it is most effective if given before a person is sexually active. In addition, even vaccinated women will still need to have a Pap test to screen for cervical cancer, as the vaccine does not protect against all types of HPV. Pathologists, physicians who study tissues and cells to identify cervical cancer and other diseases, recommend that the Pap test is still the most effective tool to detect cervical cancer.

If you would like to interview a CAP spokesperson about cervical cancer, HPV or Pap testing, please e-mail us at PublicAffairs@cap.org or call 800-323-4040 ext. 7538

In the media kit:

Additional Information Related to Cervical Cancer From MyBiopsy.org

Related CAP Public Statements

 
 

 

 

   
 
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed